Pharmacokinetic Optimisation of Drug Therapy in Elderly Patients

Tomita DK, Kennedy DL, Baum C, et al. Drug utilization in the United States — 1988: tenth annual review. (Reproduced by US Dept of Commerce, National Technical Information Service, Springfield, VA 22161.) Rockville, MD: US Dept of Health and Human Services (PB90-150921), 1989: 1–44 US Bureau of Census. Demographic and socioeconomic aspects of aging in the United States. Current Population Reports, ser P-23, no. 138. Washington DC: Government Printing Office, 1984 Nolan L, O’Malley K. Prescribing for the elderly: part I. Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988; 36: 142–9 Vestal RE. Clinical pharmacology. In: Hazzard WR, Andres R, Bierman EL, et al., editors. Principles of geriatric medicine and gerontology. 2nd ed. New York: McGraw-Hill, 1990: 201–11 Parker BM, Vestal RE. Pharmacokinetics of anticonvulsant drugs in the elderly. In: Wyllie E, editor. The treatment of epilepsy. Philadelphia: Lea and Febiger, 1993: 769–74 Balin AK. Aging of the human skin. In: Hazzard WR, Andres R, Bierman EL, et al., editors. Principles of geriatric medicine and gerontology. 2nd ed. New York: McGraw-Hill, 1990: 383–412 Vestal RE, Montamat SC, Nielson CP. Drugs in special patient groups: the elderly. In: Melmon KL, Morelli HF, Hoffman BB, et al., editors. Clinical pharmacology — basic principles in therapeutics. 3rd ed. New York: Macmillan, 1992: 851–74 Wallace SM, Verbeeck RG. Plasma protein binding of drugs in the elderly. Clin Pharmacokinet 1987; 12: 41–72 Vestal RE, Cusack BJ. Pharmacology and aging. In: Schneider EL, Rowe JW, editors. Handbook of the biology of aging. 3rd ed. San Diego: Academic Press, 1990: 349–83 Schmucker DL, Woodhouse KW, Wang RK, et al. Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 1990; 48(4): 365–74 Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41 Lamy PP. Adverse drug effects. Clin Geriatr Med 1990; 6(2): 293–307 Jue SG, Vestal RE. Adverse drug reactions in the elderly: a critical review. In: O’Malley K, editor. Medicine in old age — clinical pharmacology and drug therapy. London: Churchill-Livingstone, 1985: 52 Feely J, Coakley D. Altered pharmacodynamics in the elderly. Clin Geriatr Med 1990; 6(2): 269–83 Pan HY, Hoffman BB, Pershe RA, et al. Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther 1986; 239(3): 802–7 Routledge PA, Chapman PH, Davies DM, et al. Pharmacokinetics and pharmacodynamics of warfarin at steady state. Br J Clin Pharmacol 1979; 8: 243–7 Kaiko RF, Wallenstein SL, Rogers AG, et al. Narcotics in the elderly. Med Clin North Am 1982; 66(5): 1079–89 Scott JC, Stanski DR. Decreased fentanyl and alfentanil requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240(1): 159–66 World Health Organization. Health care in the elderly: report of the technical group on the use of medicaments by the elderly. Drugs 1981; 22: 279–94 Cusack B, Kelly J, O’Malley K, et al. Digoxin in the elderly: pharmacokinetic consequences of old age. Clin Pharmacol Ther 1979; 25: 772–6 Fenster PE, Nolan PE. Antiarrhythmic drugs. In: Bressler R, Katz MD, editors. Geriatric pharmacology. New York: McGraw-Hill, 1993: 105–49 Messerli FH, Losem CJ. Antihypertensive therapy in the elderly. Clin Geriatr Med 1990; 6(2): 335–44 Cadieux RJ. Geriatric psychopharmacology: a primary care challenge. Postgrad Med 1993; 93(4): 281–301 Bressler R, Katz MD. Drug therapy for geriatric depression. Drugs Aging 1993; 3(3): 195–219 Salzman C. Antidepressants. Clin Geriatr Med 1990; 4(2): 399–410 Rubin EH, Biggs JT, Preskorn SH. Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice. J Clin Psychiatry 1985; 46(10): 418–24 Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly: therapeutic considerations (Part II). Clin Pharmacokinet 1991; 21(4): 262–73 Owen JA, Sitar DA, Berger L, et al. Age related morphine kinetics. Clin Pharmacol Ther 1983; 34(3): 364–8 Holdsworth M, Forman WB. Pain control. In: Bressler R, Katz MD, editors. Geriatric pharmacology. New York: McGraw-Hill, 1993: 207–29 Woodhouse KW, Wynne H. The pharmacokinetics of nonsteroidal anti-inflammatory drugs in the elderly. Clin Pharmacokinet 1987; 12: 111–22 Upton RA, Williams RL, Kelly J, et al. Naproxen pharmacokinetics in the elderly. Br J Clin Pharmacol 1984; 18: 207–14 Advenier C, Roux A, Gobert C, et al. Pharmacokinetics of ketoprofen in the elderly. Br J Clin Pharmacol 1983; 16: 65–70 Greenblatt DJ, Abernathy DR, Matlis R, et al. Absorption and disposition of ibuprofen in the elderly. Arthritis Rheum 1984; 27(9): 1066–9 Longe RL, Smith OB. Phenytoin interaction with an oral feeding results in loss of seizure control. J Am Geriatr Soc 1988; 36: 542–4 Olsen KM, Hiller FC, Ackerman BH, et al. Effect of enteral feedings on oral phenytoin absorption. Nutr Clin Pract 1989; 4: 176–8 Hockings N, Pall A, Moody J, et al. The effect of age on carbamazepine pharmacokinetics and adverse effects. Br J Clin Pharmacol 1986; 22: 725–8 Bauer LA, Davis R, Wilensky A, et al. Valproic acid clearance: unbound fraction and diurnal variation in young and elderly subjects. Clin Pharmacol Ther 1985; 37: 697–700 Vestal RE, Dawson GW. Pharmacology and aging. In: Finch CE, Schneider EL, editors. Handbook of the biology of aging. 2nd ed. New York: Van Nostrand, 1985: 744–819